Sandy Draper
Stock Analyst at Guggenheim
(2.92)
# 1,668
Out of 4,996 analysts
119
Total ratings
59.38%
Success rate
20.16%
Average return
Main Sectors:
Stocks Rated by Sandy Draper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Buy | $464 → $432 | $496.79 | -13.04% | 12 | Jul 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Neutral | n/a | $179.56 | - | 8 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $148.56 | - | 15 | Feb 15, 2024 | |
| EVH Evolent Health | Maintains: Hold | $36 → $34 | $8.95 | +279.89% | 9 | Nov 14, 2023 | |
| GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $4.04 | +147.52% | 4 | Aug 10, 2023 | |
| DOCS Doximity | Downgrades: Neutral | n/a | $74.40 | - | 3 | Aug 9, 2023 | |
| TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $3.54 | -43.50% | 3 | Jun 16, 2023 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $271 → $263 | $163.79 | +60.57% | 13 | Apr 28, 2023 | |
| AGL agilon health | Maintains: Buy | $21 → $30 | $1.09 | +2,652.29% | 3 | Mar 6, 2023 | |
| HQY HealthEquity | Maintains: Buy | $89 → $94 | $96.53 | -2.62% | 11 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $8.16 | - | 10 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $51 | $23.98 | +112.68% | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $143 → $129 | $162.97 | -20.84% | 2 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $55 | $33.44 | +64.47% | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $226 → $168 | $53.57 | +213.61% | 2 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $12 | $58.40 | -79.45% | 1 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $33 → $38 | $27.81 | +36.64% | 7 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $6.04 | +727.81% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $7.93 | +719.67% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $2.80 | +1,185.71% | 4 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $167 | $290.27 | -42.47% | 3 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.46 | - | 2 | May 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $13.85 | +354.87% | 1 | Sep 20, 2016 |
Medpace Holdings
Jul 24, 2024
Maintains: Buy
Price Target: $464 → $432
Current: $496.79
Upside: -13.04%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $179.56
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $148.56
Upside: -
Evolent Health
Nov 14, 2023
Maintains: Hold
Price Target: $36 → $34
Current: $8.95
Upside: +279.89%
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $4.04
Upside: +147.52%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $74.40
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $3.54
Upside: -43.50%
ICON Public Limited Company
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $163.79
Upside: +60.57%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $1.09
Upside: +2,652.29%
HealthEquity
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $96.53
Upside: -2.62%
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $8.16
Upside: -
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $23.98
Upside: +112.68%
May 25, 2021
Maintains: Buy
Price Target: $143 → $129
Current: $162.97
Upside: -20.84%
May 18, 2021
Maintains: Buy
Price Target: $84 → $55
Current: $33.44
Upside: +64.47%
May 12, 2021
Maintains: Buy
Price Target: $226 → $168
Current: $53.57
Upside: +213.61%
Apr 21, 2021
Initiates: Hold
Price Target: $12
Current: $58.40
Upside: -79.45%
Feb 4, 2021
Maintains: Hold
Price Target: $33 → $38
Current: $27.81
Upside: +36.64%
Jan 28, 2021
Initiates: Buy
Price Target: $50
Current: $6.04
Upside: +727.81%
Jan 28, 2021
Initiates: Buy
Price Target: $65
Current: $7.93
Upside: +719.67%
May 13, 2020
Maintains: Buy
Price Target: $30 → $36
Current: $2.80
Upside: +1,185.71%
Mar 26, 2020
Maintains: Buy
Price Target: $175 → $167
Current: $290.27
Upside: -42.47%
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.46
Upside: -
Sep 20, 2016
Initiates: Buy
Price Target: $63
Current: $13.85
Upside: +354.87%